Abstract: Provided are compounds useful for treating of cancer and methods for treating of cancer, comprising administering to a subject in need thereof a compound described therein.

Abstract: This application provides a battery cell, a battery, and an electrical device, and relates to the technical field of batteries. The battery cell includes an electrode assembly. A plurality of weld portions are disposed on one side of a first electrode plate of the electrode assembly along a width direction. The plurality of weld portions are spaced apart along a length direction of the first electrode plate. The first electrode plate includes a winding start end and a winding termination end. The first electrode plate includes a body section from a first weld portion to a second weld portion. The body section is equally divided into a plurality of subsections, each subsection being L in length. A total length of the weld portions of each subsection is not less than 5%×L, where 200 mm?L?1200 mm.

Abstract: A live detection system, a thermal infrared (IR) imager and a method for power grid equipment are provided. The system includes an environmental parameter module for acquiring environmental temperature, humidity and wind speed data; a ranging module for measuring a linear distance to the power grid equipment; an equipment type recognition module for acquiring an image of the power grid equipment, and recognizing a type of the power grid equipment; an equipment material determination module for determining a material type of the power grid equipment; an emissivity setting module for setting an emissivity; an temperature measurement module for obtaining a temperature of the power grid equipment by focusing on positions of the power grid equipment which need temperature measurement; and a report generation module for selecting a corresponding diagnostic model, displaying a temperature measurement position and a temperature value, drawing a conclusion, and generating a report.

Abstract: A high voltage battery cluster, and an overcurrent protection circuit and a switch box of the high voltage battery cluster are provided. The overcurrent protection circuit includes a first fusing module and a second fusing module. Since a withstand current-time curve of the first fusing module is different from a withstand current-time curve of the second fusing module, in a case that an overcurrent fault occurs in a high voltage battery cluster, one fusing module can cause an open circuit in the high voltage battery cluster prior to another fusing module, thereby preventing the high voltage battery cluster from being broken by a large current when an overcurrent fault occurs in the high voltage battery cluster, thus ensuring an electrical safety of the high voltage battery cluster.

Abstract: The present disclosure provides a positioning method, including: obtaining a current local topology map established based on objects in an environment currently observed by a robot, obtaining a full topology map pre-established based on objects in a full environment in a preset area, the current local topology map and the full topology map including nodes representing the objects; matching a node pair to be associated constructed by two nodes in the current local topology map and two nodes in the full topology map; if a degree of association of the node pair to be associated is greater than a threshold, determining that the node pair to be associated is an associated node pair; and determining a pose of the robot according to one of a plurality of search ranches, with a largest number of associated node pairs.

Abstract: The knob screen device includes a glass touch cover plate, a display screen, a screen support frame, a semi-transparent turning structure, an annular light-leading friction shim, at least one battery, a mainboard and a magnetic attraction assembly. The knob screen device further comprises: at least one Hall sensor provided on the mainboard; at least one multicolor LED ambient light provided on the mainboard; and at least one annular multipolar flexible magnet provided in the semi-transparent turning structure. The semi-transparent turning structure is connected to external component by means of the magnetic attraction assembly. In this way, the knob screen device is simple in structure, low in cost, easy to process and install and more flexible in application circumferences.

Abstract: A method for controlling operations of an asynchronous FIFO memory includes: determining a current depth of the asynchronous FIFO memory according to at least one of a clock ratio, a burst length and a continuous transmission length, where the clock ratio is a ratio of a frequency of a first clock signal used by a master device to a frequency of a second clock signal used by a slave device; configuring one or more entries of the asynchronous FIFO memory to be used according to the current depth; and controlling a plurality of FIFO clock signals provided to the asynchronous FIFO memory according to the current depth. One FIFO clock signal corresponds to one entry, and one or more FIFO clock signals corresponding to one or more entries that are not configured according to the current depth are disabled.

Abstract: Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

Abstract: Embodiments of this application provide a battery cell, a battery, and an electric apparatus. The battery cell may include an electrode assembly, a housing, an electrode terminal, and a current collector. The electrode assembly may include a first tab. The housing may be configured to accommodate the electrode assembly. The electrode terminal may be disposed in the housing, and the electrode terminal may include a first concave portion and a connecting portion at the bottom of the first concave portion. The current collector may be connected to the first tab and welded to the connecting portion.

Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Abstract: A battery cell includes a housing, an electrode assembly, an end cover, and a current collecting member. The housing has an opening, the electrode assembly has a tab, the electrode assembly is configured to be accommodated in the housing, the end cover is configured to cover the opening, and the current collecting member is configured to connect the end cover to the tab to implement electrical connection between the end cover and the tab. The current collecting member is welded to the tab to form a first welded portion and a second welded portion, the current collecting member is welded to the end cover to form a third welded portion, the first welded portion is on an inner peripheral side of the third welded portion, and the second welded portion is on an outer peripheral side of the third welded portion.

Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Abstract: A method for controlling operations of an asynchronous FIFO memory includes: determining a current depth of the asynchronous FIFO memory according to at least one of a clock ratio, a burst length and a continuous transmission length, where the clock ratio is a ratio of a frequency of a first clock signal used by a master device to a frequency of a second clock signal used by a slave device; configuring one or more entries of the asynchronous FIFO memory to be used according to the current depth; and controlling a plurality of FIFO clock signals provided to the asynchronous FIFO memory according to the current depth. One FIFO clock signal corresponds to one entry, and one or more FIFO clock signals corresponding to one or more entries that are not configured according to the current depth are disabled.

Abstract: A battery cell, a battery, an electric device, and a manufacturing device and method of battery cell are described. The battery cell includes a metal housing, an electrode assembly, and a conductive member, where the metal housing has an accommodating cavity; the electrode assembly is accommodated in the accommodating cavity, the electrode assembly includes a first tab, and the first tab is electrically connected to the metal housing; and the conductive member is disposed on an outer surface of the metal housing, and resistance of the conductive member is lower than that of the metal housing. In the charging and discharging process, current passes through the conductive member or passes through both the conductive member and the metal housing, in whichever cases, the resistance in the charging and discharging process of the battery cell is lower than that in the case of current passing through the metal housing only.

Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Abstract: Provided are compounds and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.

Abstract: Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

Abstract: Provided herein is a tablet comprising 2-methyl-1-[(4-[-6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Abstract: Provided herein is a tablet comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof.